Levoleucovorin
Levoleucovorin is a prescription injectable solution used to reduce the toxic effects of chemotherapy drugs like methotrexate. Available in 175 mg or 250 mg vials for intravenous use, it's manufactured by Gland Pharma and Dr. Reddy's Laboratories under ANDA210892. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Levoleucovorin is a prescription injectable solution used to reduce the toxic effects of chemotherapy drugs like methotrexate. Available in 175 mg or 250 mg vials for intravenous use, it's manufactured by Gland Pharma and Dr. Reddy's Laboratories under ANDA210892. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Levoleucovorin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Levoleucovorin — ANDA 206263 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206263"
}
]
|
| identifier | ANDA206263 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"health-care",
"medications",
"pharmaceuticals"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Levoleucovorin |
